WILLIAM TED BROWN, MD, PHD
Medical Practice at Forest Hill Rd, Staten Island, NY
License number
New York 124025
Category
Medical Practice
Type
Clinical Genetics (M.D.)
Address
Address
1050 Forest Hill Rd, Staten Island, NY 10314
Phone
(718) 494-5117
(718) 494-2258 (Fax)
(718) 494-2258 (Fax)
Personal information
See more information about WILLIAM TED BROWN at radaris.comName
Address
Phone
511 County Route 16, Fort Ann, NY 12827
50 Whiskey Hill Rd, Wallkill, NY 12589
50 Smith Ridge Rd, South Salem, NY 10590
512 Mother Gaston Blvd Apt 1B, Brooklyn, NY 11212
5168 Marrowback Rd, Hemlock, NY 14466
Professional information
See more information about WILLIAM TED BROWN at trustoria.com
Dr. William T Brown, Staten Island NY - MD (Doctor of Medicine)
Dr. William T Brown, Staten Island NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Clinical Genetics
Address:
George A Jervis Clinic
1050 Forest Hill Rd, Staten Island 10314
(718) 494-5151 (Phone)
1050 Forest Hill Rd, Staten Island 10314
(718) 494-5151 (Phone)
Certifications:
Clinical Genetics, 1982, Internal Medicine, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
George A Jervis Clinic
1050 Forest Hill Rd, Staten Island 10314
Richmond University Medical Center
355 Bard Ave, Staten Island 10310
Staten Island University Hospital
475 Seaview Ave, Staten Island 10305
1050 Forest Hill Rd, Staten Island 10314
Richmond University Medical Center
355 Bard Ave, Staten Island 10310
Staten Island University Hospital
475 Seaview Ave, Staten Island 10305
Education:
Medical School
Harvard Medical School
Graduated: 1974
St Lukes-Roosevelt Hospital Center At Roosevelt Division
New York Presbyterian Hospital-New York Weill Cornell Center
Harvard Medical School
Graduated: 1974
St Lukes-Roosevelt Hospital Center At Roosevelt Division
New York Presbyterian Hospital-New York Weill Cornell Center
William Brown - Staten Island, NY
William Brown - Staten Island, NY
Work:
Adesta, Lourdes, CTS, Hentel Comunications, Pyramid
Communications Consultant - Client Verizon FIOS - Dover, NJ
Manager Verizon FIOS - Staten Island, NY
Manager Verizon - Staten Island, NY
Dispatch Foreman Verizon - Staten Island, NY
Manager Bell Atlantic - Brooklyn, NY
Field Foreman
Communications Consultant - Client Verizon FIOS - Dover, NJ
Manager Verizon FIOS - Staten Island, NY
Manager Verizon - Staten Island, NY
Dispatch Foreman Verizon - Staten Island, NY
Manager Bell Atlantic - Brooklyn, NY
Field Foreman
Education:
Empire State College - New York, NY
Leadership and Management
Leadership and Management
William Francis Brown, Staten Island NY
William Francis Brown, Staten Island NY
Specialties:
Anesthesiologist
Address:
1050 Forest Hill Rd, Staten Island, NY 10314
Education:
Pennsylvania State University, College of Medicine - Doctor of Medicine
Children's Hospital of Pittsburgh - Fellowship - Pediatric Anesthesiology
Children's Hospital of Pittsburgh - Fellowship - Pediatric Anesthesiology
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology
William Ted Brown, Staten Island NY
William Ted Brown, Staten Island NY
Specialties:
Internal Medicine, Anesthesiology, Medical Genetics, Clinical Genetics, M.D., Clinical Cytogenetic
Work:
Inst For Basic Research
1050 Forest Hill Rd, Staten Island, NY 10314
1050 Forest Hill Rd, Staten Island, NY 10314
Education:
Harvard University(1974)
William Ted Brown, Staten Island NY
William Ted Brown, Staten Island NY
Specialties:
Internist
Address:
1050 Forest Hill Rd, Staten Island, NY 10314
Lmna Gene And Its Involvement In Hutchinson-Gilford Progeria Syndrome (Hgps) And Arteriosclerosis
Lmna Gene And Its Involvement In Hutchinson-Gilford Progeria Syndrome (Hgps) And Arteriosclerosis
US Patent:
2014007, Mar 13, 2014
Filed:
Sep 12, 2013
Appl. No.:
14/025497
Inventors:
William Ted Brown - Staten Island NY, US
International Classification:
C12Q 1/68
US Classification:
435 611, 436501, 536 235, 536 2431, 435 792
Abstract:
Disclosed herein are point mutations in the LMNA gene that cause HGPS. These mutations activate a cryptic splice site within the LMNA gene, which leads to deletion of part of exon 11 and generation of a mutant Lamin A protein product that is 50 amino acids shorter than the normal protein. In addition to the novel Lamin A variant protein and nucleic acids encoding this variant, methods of using these molecules in detecting biological conditions associated with a LMNA mutation in a subject (e.g., HGPS, arteriosclerosis, and other age-related diseases), methods of treating such conditions, methods of selecting treatments, methods of screening for compounds that influence Lamin A activity, and methods of influencing the expression of LMNA or LMNA variants are also described. Oligonucleotides and other compounds for use in examples of the described methods are also provided, as are protein-specific binding agents, such as antibodies, that bind specifically to at least one epitope of a Lamin A variant protein preferentially compared to wildtype Lamin A, and methods of using such antibodies in diagnosis, treatment, and screening. Also provided are kits for carrying out the methods described herein.
System And Method For Quantifying Fragile X Mental Retardation 1 Protein In Tissue And Blood Samples
System And Method For Quantifying Fragile X Mental Retardation 1 Protein In Tissue And Blood Samples
US Patent:
8628934, Jan 14, 2014
Filed:
Jun 11, 2012
Appl. No.:
13/493318
Inventors:
Giuseppe LaFauci - Old Bridge NJ, US
William T. Brown - Staten Island NY, US
Richard Kascsak - Morganville NJ, US
William T. Brown - Staten Island NY, US
Richard Kascsak - Morganville NJ, US
Assignee:
The Research Foundation For Mental Hygiene, Inc. - Menands NY
International Classification:
G01N 33/53, G01N 33/68
US Classification:
435 794, 435 71, 436 86
Abstract:
A system and method for the detection and quantification of fragile X mental retardation protein (FMRP) in human tissue and blood samples. The system includes several high avidity monoclonal antibodies that may be provided on Xmap microspheres to capture FMRP from a tissue or blood specimen. The resulting complex is reacted with a polyclonal anti-FMRP rabbit antibody and then mixed with an anti-rabbit IgG antibody conjugated to phycoerythrin. Fluorescence emitted from the resulting complex is a function of the amount of FMRP present in the specimen.